Parisian startup Cardiawave has raised more than $8 million to boost development of its ultrasound device to treat calcific aortic stenosis.
Nearly $3 million came from the European program Instrument PME, which finances disruptive European technologies developed by potentially high-growth companies. Family-controlled investment groups and the company’s traditional shareholders — Sofimac Innovation, Business Angels des Grandes Ecoles, Paris Business Angels, Angels Santé and Angels’ Bay Invest — put in another $5.3 million.